Ravulizumab Outcomes in Polish Patients With aHUS
NCT07399730
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Atypical Hemolytic Uremic Syndrome
Interventions
DRUG:
Ravulizumab
Sponsor
AstraZeneca